World Investment Advisors’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.11M Sell
6,038
-44
-0.7% -$8.42K 0.02% 671
2026
Q1
$1.12M Sell
6,082
-657
-10% -$121K 0.02% 678
2025
Q4
$1.19M Buy
6,739
+317
+5% +$51.8K 0.02% 630
2025
Q3
$900K Sell
6,422
-56
-0.9% -$7.57K 0.02% 595
2025
Q2
$814K Buy
6,478
+184
+3% +$22.9K 0.02% 573
2025
Q1
$861K Sell
6,294
-17
-0.3% -$2.43K 0.02% 548
2024
Q4
$965K Buy
6,311
+545
+9% +$91.9K 0.03% 480
2024
Q3
$1.12M Buy
+5,766
New +$1.21M 0.04% 400

Other funds holding BIIB

World Investment Advisors's BIIB Position: Q2 2026 in Review

World Investment Advisors reduced its Biogen (BIIB) stake by 0.72% in Q2 2026, selling an estimated $8.42K and leaving 6,038 shares worth $1.11M. The position accounts for 0.02% of the portfolio, ranked #671.

World Investment Advisors first reported a position in BIIB in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.19M in Q4 2025. 1,038 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • World Investment Advisors held 6,038 shares of Biogen worth $1.11M as of Q2 2026.
  • World Investment Advisors sold 44 Biogen shares in Q2 2026, an estimated $8.42K.
  • Biogen made up 0.02% of World Investment Advisors's portfolio in Q2 2026, its #671 holding.
  • World Investment Advisors first reported a position in Biogen in Q3 2024 and has held it in 8 quarters since.
  • World Investment Advisors's Biogen position peaked at $1.19M in Q4 2025.
  • 1,038 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on World Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.